Alliance Pharma PLC Grant of Options to Directors (1320D)
05 October 2018 - 7:25PM
UK Regulatory
TIDMAPH
RNS Number : 1320D
Alliance Pharma PLC
05 October 2018
5 October 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Grant of Options to Directors
Alliance Pharma plc (AIM: APH), the international specialty
pharmaceutical group, announces that the Board has issued options
over an aggregate of 1,428,000 ordinary shares of 1 pence each in
the Company ("Share Options"), on the recommendation of the
Company's Remuneration Committee, to the Directors detailed
below.
Peter Butterfield, Chief Executive Officer, has been awarded a
total of 1,250,000 Share Options. 1,000,000 Share Options have been
granted to Mr Butterfield in connection with his appointment on 1
May 2018 as CEO and in recognition of the additional
responsibilities that he has assumed. 250,000 have been granted
under the Company's 2015 Unapproved Share Option Plan.
Andrew Franklin, Chief Financial Officer, has been awarded a
total of 178,000 Share Options pursuant to the Company's 2015
Unapproved Share Option Plan.
The Share Options granted all have an exercise price of 81.6p,
being the closing mid-market price on 19 September 2018, the date
of announcement of the Company's half year results for 2018, and
become exercisable on 19 September 2021, being the third
anniversary of the date of the grant, subject to continued
employment and the satisfaction of certain performance conditions
measured by growth targets in the Company's diluted earnings per
share over that three year period.
The net effect of the grant of Share Options and the resultant
option holdings are shown in the table below:
Name Share Options granted Total no. of options
over ordinary shares
now held
Peter Butterfield 1,250,000 5,804,803
---------------------- ----------------------
Andrew Franklin 178,000 2,903,000
---------------------- ----------------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by person
discharging managerial responsibilities.
1 Details of the person discharging managerial
responsibilities/person closely associated
a) Name Mr Peter Butterfield
---------------------- ------------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------
a) Position/status Chief Executive Officer - Director
---------------------- ------------------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------- ------------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
------------------------------------------------------------------------
a) Name Alliance Pharma plc
---------------------- ------------------------------------------------
b) Legal Entity N/A
Identifier
---------------------- ------------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
------------------------------------------------------------------------
a) Description Ordinary shares of 1.0 pence each
of the financial ISIN: GB0031030819
instrument,
type of instrument
Identification
code
---------------------- ------------------------------------------------
b) Nature of the Grant of Options
transaction
---------------------- ------------------------------------------------
c) Currency GBP
---------------------- ------------------------------------------------
d) Price(s) and Exercise Price No. of share options
volume(s) (p)
---------------------- -------------------- --------------------------
81.6p 1,250,000
--------------------------- -------------------- --------------------------
e) Aggregated Grant of 1,250,000 options to acquire
information shares at GBP0.816 per share at
-Aggregated an aggregate exercise price of GBP1,020,000
volume
- Price
- Aggregated
total
---------------------- ------------------------------------------------
f) Date of the 5 October 2018
transaction
---------------------- ------------------------------------------------
g) Place of the London Stock Exchange, AIM
transaction
---------------------- ------------------------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
a) Name Mr Andrew Franklin
---------------------- ----------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------
a) Position/status Chief Financial Officer - Director
---------------------- ----------------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
----------------------------------------------------------------------
a) Name Alliance Pharma plc
---------------------- ----------------------------------------------
b) Legal Entity N/A
Identifier
---------------------- ----------------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
----------------------------------------------------------------------
a) Description Ordinary shares of 1.0 pence each
of the financial ISIN: GB0031030819
instrument,
type of instrument
Identification
code
---------------------- ----------------------------------------------
b) Nature of the Grant of Options
transaction
---------------------- ----------------------------------------------
c) Currency GBP
---------------------- ----------------------------------------------
d) Price(s) and Exercise Price No. of share options
volume(s) (p)
---------------------- ------------------- -------------------------
81.6p 178,000
--------------------------- ------------------- -------------------------
e) Aggregated Grant of 178,000 options to acquire
information shares at GBP0.816 per share at
- Aggregated an aggregate exercise price of GBP145,248
volume
- Price
- Aggregated
total
---------------------- ----------------------------------------------
f) Date of the 5 October 2018
transaction
---------------------- ----------------------------------------------
g) Place of the London Stock Exchange, AIM
transaction
---------------------- ----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHUGGPPUUPRUBA
(END) Dow Jones Newswires
October 05, 2018 05:25 ET (09:25 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024